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Background: Age is the leading risk factor for acute and chronic neurodegenerative diseases. The Shen Nong Ben Cao
Jing, the oldest known compendium of Chinese materia media, lists herbal medicines that were believed to exert neither
fast acting pharmacological effects nor discernible toxicity, but to promote general health and longevity. In modern
terms, these herbal medicines could be considered as complementary health care products for prevention rather than
treatment of diseases. In the present study, we examined whether a selection of 13 such herbal medicines exhibited
neuroprotective activity.
Methods: The antioxidant capacity of the herbal extracts was determined using three non-cellular assays measuring the
total phenol content (FCR assay), 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging capacity and oxygen radical
absorbance capacity (ORAC). Cytotoxic effects of the herbal extracts were assayed in cultured mouse cortical neurons
and their neuroprotective activities were studied using staurosporine-induced apoptosis of the cultured neurons.
Results: Most of the herbal extracts showed negligible toxic effects at 100 μg/ml. However, Polygonum multiflorum and
Rhodiola rosea exhibited some neurotoxicity at this concentration. Extracts of Ganoderma lucidum, Glycyrrhiza glabra,
Schizandra chinensis, and Polygonum cuspidatum inhibited staurosporine-induced apoptosis by 30 – 50% in a dose-
dependent manner. The neuroprotective effects of Polygonum cuspidatum were predominantly due to its major
ingredient, resveratrol. The effective herbal extracts showed various levels of reactive oxygen species (ROS) scavenging
capacity, which was significantly correlated with their neuro- protective activity. However, P. multiflorum and R. rosea
extracts proved to be the exception as they exhibited a high level of antioxidant capacity, but did not exhibit
neuroprotective effects in cell-based assay.
Conclusions: This in vitro study provides evidence for neuroprotective activity of some Chinese herbal medicines
traditionally used to promote healthy ageing and longevity. Our results provide a justification for further study of these
herbal extracts in neurodegenerative animal models to assess their safety and effectiveness as a basis for subsequent
clinical trials. These herbal medicines might potentially offer a novel preemptive neuroprotective approach in
neurodegenerative diseases and might be developed for use in persons at risk.
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Age is the leading risk factor for acute and chronic neuro-
degenerative diseases such as stroke, Parkinson’s and
Alzheimer’s disease. As population ageing is occurring on
a global scale, the incidence of these diseases is likely to
increase significantly in the near future. To date, there is a
lack of effective preventive strategies for these disorders.
Furthermore, treatments are mainly symptomatic and can
at best temporarily slow down disease progression. A large
body of basic molecular neuroscience research over the
last 30 years has led to the elucidation of the molecular
mechanisms involved in the events leading to neuronal in-
jury and death. Multiple lines of evidence from a large
number of in vitro, in vivo and post mortem studies indi-
cate that the demise of neurons is often the result of the
activation of common (shared) cell death programs such
as apoptosis [1]. Research has also demonstrated that
pharmacological or genetic manipulation of the underlying
molecular pathways can protect neurons from deadly in-
sults [2-4]. The strategy aimed at antagonizing, interrupt-
ing or slowing the molecular events leading to irreversible
injury or death of neurons in neurodegenerative diseases
is commonly referred to as neuroprotection [5-7]. How-
ever, the poor translation from animal studies to clinical
trials has disappointed neurologists and aroused hot de-
bate on reasons for the apparent failure of neuroprotec-
tion as an effective treatment for neurodegenerative
diseases [7-10].
A lack of treatment options has led to an increasing
number of people to use “natural” and herbal medicines in
an attempt to prevent or delay the deleterious effects of
ageing. Longevity and good health have always been desir-
able goals for humans. The Shen Nong Ben Cao Jing (Shen
Nong’s Herbal; compiled some 2000 years ago) is the first
known example of an extensive body of literature devoted
to the description and classification of the Chinese materia
medica and many later books on Chinese materia medica
carry the term “ben cao” in their title. It contains the de-
scription of some 365 drugs that were grouped into three
classes. The drugs in the top class neither exerted fast act-
ing pharmacological effects nor any discernible toxicity.
They were believed to promote general health and longev-
ity when they were taken daily on a long-term basis. In
modern terms, these drugs could be considered as comple-
mentary health care products such as functional foods or
nutraceuticals aimed at promoting health and the preven-
tion rather than the treatment of diseases.
Oxidative stress has been implicated in the pathogenesis
of both acute and chronic neurodegenerative diseases and
is believed to play a role in ageing, which is the key risk
factor for neurodegenerative diseases [11]. Chinese herbal
medicines are known to be a rich source of antioxidants
and their purported therapeutic effects are often linked to
their antioxidant activity [12]. Along these lines, we setout to investigate whether or not a sample of Chinese
herbal medicines used to promote general health and lon-
gevity exhibit cytoprotective effects towards neurons and
glia in the central nervous system and to test the hypoth-
esis that any such effects were correlated with their anti-
oxidant activity. Here we report that some of the selected
herbal extracts exhibited neuroprotective activity in a
well-established in vitro model of neuronal apoptosis in-
duced by the non-selective protein kinase inhibitor staur-
osporine [13,14]. While the neuroprotective activity was
correlated with the antioxidant capacity of the extracts,
two extracts (Polygonum multiflorum and Rhodiola rosea)
with high anti-oxidant capacity lacked neuroprotective ac-
tivity in the staurosporine assay and exhibited some
neurotoxic activity when they were applied in the absence
of staurosporine. These results complement our previous
study reporting on the cytoprotective properties of these
extracts in glial cells [15]. Interestingly, some extracts ex-
hibited selective protection in neurons but not glia (Polyg-
onum cuspidatum) or glia but less so in neurons (P.
multiflorum). Together, the data appear to support the
traditional practice of combining multiple herbal medi-
cines for the treatment of complex disorders [15]. The re-
sults of this study provide a justification for further testing
of these herbal extracts in neurodegenerative animal
models to assess their safety and effectiveness in vivo as a
basis for subsequent clinical studies in humans. In the ab-
sence of known adverse effects, these herbal medicines
might offer a novel preemptive neuroprotective approach
in acute and chronic neurodegenerative diseases and
might be developed for prophylactic use in persons at risk.
Methods
Herbal extracts and reagents
Commercially available extracts of medicinal herbs for use
as listed herbal medicines, were provided by LIPA
Pharmaceuticals Ltd (Minto, NSW, Australia). Traceability
of the extracts to their respective (qualified botanist) au-
thenticated starting medicinal herbs was established by
the Quality Control Department at LIPA Pharmaceuticals.
The herb names, extraction solvent(s) and ratios are listed
in Additional file 1: Table S1. Among the herbal extracts,
the Polygonum cuspidatum extract was standardized to
contain 50% of trans-resveratrol. The root powder of
Radix Glycyrrhizae was used without initial extraction.
For preparation of the stock, the herbal extract powders
were further extracted with 80% of methanol under sonic-
ation for 30 min, twice, with a 15 min interval. After cen-
trifugation, the supernatant was filtered and evaporated
under vacuum to obtain a dried powder, which was re-
ferred to as herbal extract and used in the reported experi-
ments. The higher strength of organic solvent (80%
methanol) was expected to maximize the extraction of
both moderately polar and polar constituents in the
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hydro-alcoholic mixtures.
For the biological experiments, the dried herbal extracts
were dissolved in dimethyl sulfoxide (DMSO) to obtain
100 mg/ml stock solutions. Pure compounds, which are
possible active ingredients in selective herbal extracts,
such as trans-resveratrol, glabridin, and schisandrin, were
purchased from Phytomarker (Tianjin, China). The com-
pounds were freshly dissolved in DMSO to obtain 85 –
130 mg/ml stock solutions and then further diluted to
working concentrations as indicated in the figures. The
culture media and reagents were purchased from Life
Technologies. All other reagents were purchased from
Sigma unless otherwise stated.
Neuronal cell culture
The Animal Care and Ethics Committee of the University
of Western Sydney approved the use of animals in this
study. BALB/c laboratory mice at day 18 of gestation were
purchased from the Animal Resources Centre, Western
Australia. Cerebral cortical neurons from mouse embryos
were isolated and cultured as described previously [16]
with some modifications. Briefly, the cortex tissue was dis-
sected and then digested with 0.25% trypsin, followed by
triturating in Hank's balanced salt solution (HBSS, without
Ca2+ and Mg2+) supplemented with 5 mM 4-(2-hydro-
xyethyl)-1-piperazineethanesulfonic acid (HEPES). The
cells were filtered through 70 μm meshes into 2 vol. of
HBSS containing Ca2+ and Mg2+. After centrifugation at
1000 rpm for 5 min, the cell pellet was re-suspended in
plating medium consisting of neurobasal medium supple-
mented with 0.5 mM GlutaMax, 25 μM glutamate, 2%
B27 supplement and 1% Pen-Strep (Life Technology). The
cells were seeded in poly-D-lysine (PDL)-coated 96-well
or 24-well culture plates. After 2–3 days, half of the
medium was replaced with fresh culture medium and
twice weekly thereafter until the cultures were used in the
experiments. The neuronal cell cultures were maintained
at 37°C, 5% CO2 in 95% air for up to 10 days.
Neurotoxicity assay
The widely accepted staurosporine induced apoptosis
model used in this study was based on the previously estab-
lished methods [17,18] with some modifications. In prelim-
inary experiments, primary mouse cortical neuron cultures
were exposed to various concentrations of staurosporine
(10 to 800 nM) followed by assessment of apoptotic cell
death to establish a dose–response curve. Staurosporine-
induced cell death was dose-dependent with an EC50 of 130
nM (data not shown). A staurosporine concentration of
500 nM induced maximum cell death and was therefore
used for all subsequent experiments.
The cells were exposed to herbal extracts (100 μg/ml),
staurosporine (500 nM) or, simultaneously, to staurosporineand herbal extracts. Half of the culture media were replaced
with new media containing double the final concentrations
of staurosporine and/or the herbal extracts. The cells were
incubated at 37°C, 5% CO2 for 24 h. Toxicity was deter-
mined by measuring the release of lactate dehydrogenase
(LDH) into the culture medium using the LDH cytotoxicity
detection kit (Roche Applied Science, USA). The percent-
age of cytotoxicity was calculated using the formula:
Cytotoxicity %ð Þ ¼ A‐Cminð Þ= Cmax‐Cminð Þ  100%
A= absorbance measured; Cmin = absorbance of negative
control (medium contains vehicle only); Cmax = absorb-
ance of maximum toxicity (medium contains 500 nM
staurosporine).
Non-cellular antioxidant capacity assays DPPH (2,2-
diphenyl-1-picrylhydrazyl) radical scavenging assay, oxygen
radical absorbance capacity (ORAC) assay and total phenol
assay by Folin-Ciocalteau reagent were performed as
described in detail previously [15].
LC-ESI-MS analyses
Chemical fingerprints of the re-extracted herbal extracts
in 80% methanol were obtained using liquid chromatog-
raphy - electrospray ionization - mass spectrometry (LC-
ESI-MS) analyses (not illustrated). LC-ESI-MS experi-
ments were performed on a Waters Acquity Xevo TQ
triple quadrupole mass spectrometer coupled to a binary
pump, and an autosampler (Waters, Australia). Separation
was achieved using a Waters Acquity Xevo TQ triple
quadrupole mass spectrometer coupled to an ultra per-
formance liquid chromatography binary pump, a photo-
diode-array detector, and an autosampler (Waters,
Australia). Separation was achieved on Acquity UPLC BEH
C-18 column (150 mm× 2.1 mm, 1.7 μm) attached with a
Vanguard™ BEH C18 (1.7 μm) at a mobile phase flow rate
of 0.3 ml/min, operating at room temperature. The mobile
phase consisted of 0.1% aqueous formic acid (A) and aceto-
nitrile (B). The gradient elution was used with a starting
mobile phase composition of 20%, increasing to 100% B
for 16 min. Mass spectra were acquired in both positive
and negative ionization mode using an ESI source with the
mass recorded in the range of m/z 50 – 1000.
Statistical analysis
One-way ANOVA tests were carried out with GraphPad
Prism (version 5.03). Data from triplicate cultures in 2–3
separate experiments are presented as mean ± SEM.
Data comparison between drug treated and untreated
groups were made by Dunnett post tests. A p value <
0.05 was considered statistically significant and denoted
by asterisks. The relationships between antioxidant cap-
acity and cytotoxicity data were assessed by calculation
of Pearson’s correlation coefficients.
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Some herbal extracts exhibit toxic effects in cultured
primary cortical neurons
First, we determined whether the herbal extracts (100
μg/ml for 24 hours) exerted toxic effects in cultured mouse
cortical neurons. The results demonstrated that most of the
herbal extracts showed negligible cytotoxic effects when
compared to the positive control of staurosporine-induced
cytotoxicity (defined as 100%). However, Polygonum multi-
florum and Rhodiola rosea showed approximately 40% of
cytotoxic effects compared to staurosporine-induced cyto-
toxicity at the highest concentration used in this study
(Figure 1). This finding provided experimental evidence
that this group of traditional herbal medicines might be
more toxic than traditionally claimed. Further studies are
warranted to elucidate potentially toxic component(s) in
the extracts, followed by animal studies to assess any
in vivo toxicity. At this time, however, caution should be
exerted before any of the herbal medicines that exhibited
neurotoxic effects in vitro can be recommended for safe
long-term use as in humans.
Neuroprotective effects of herbal extracts
The 13 herbal extracts were subsequently investigated
for neuroprotective effects by co-treatment of the cells
during staurosporine exposure. Ganoderma lucidum,
Glycyrrhiza glabra, Schizandra chinensis or Polygonum
cuspidatum, significantly reduced staurosporine-induced
apoptotic cell death by 32 ± 6.1%, 35 ± 2.7%, 49 ± 4.4%














































































































































Figure 1 Cytotoxic effects of herbal extracts in cultured
primary mouse cortical neurons. The neuronal cells were exposed
to 100 μg/ml of the herbal extracts for 24 h. Culture media (neurobasal
medium supplemented with 2% B-27) containing vehicle only were
used as a negative control (defined as 0%) and media containing
staurosporine were used as positive control (defined as 100%).of the neuroprotective effects of G. glabra, S. chinensis
and P. cuspidatum were examined using concentrations
of 3 – 100 μg/ml (Figure 3). Interestingly, P. cuspidatum
exhibited no protective effects in hydrogen peroxide
treated U373 astroglial cells [15].
Next, we examined whether known active ingredients
in the herbal extracts, G. glabra, S. chinensis and P. cus-
pidatum, accounted for or at least contributed to the ob-
served neuroprotective activity of the extracts. We
examined glabridin (Figure 3A, right) from G. glabra
(Figure 3A, left), schisandrin (Figure 3B, right) from S.
chinensis (Figure 3B, left) and resveratrol (Figure 3C,
right) from P. cuspidatum (Figure 3C, left) for their neu-
roprotective activity using the same procedure as for
herbal extracts, but over the concentration range of 1 –
65 μg/ml. The maximal level of neuroprotective activity
of glabridin was 30% inhibition of staurosporine-induced
cell death at 8–16 μg/ml. Resveratrol exhibited 40% in-
hibition at 23–46 μg/ml. The higher concentrations re-
sulted in less activity because the beneficial activity
appeared to be offset by toxic effects of the compounds.
In the example of glabridin, high concentrations (> 16
μg/ml) resulted in cytotoxic effects in a dose-dependent
manner. Schisandrin did not exhibit neuroprotective ac-
tivity (Figure 3).
P. cuspidatum is widely used as a traditional medicinal
herb in Asia. An increasing body of research has demon-
strated that the extracts from the root of this herb pos-
sess antioxidant activity, anti-proliferative effects on



























































































































































Figure 2 Neuroprotective effects of the herbal extracts. The
relative cytotoxicity of neuronal cells was measured for the cell
cultures (n = 3) co-treated with 100 μg/ml of the herbal extracts and
500 nM staurosporine for 24 h. * p value < 0.05; ** p value < 0.01,
and *** p value < 0.001 compared with the positive control.
Figure 3 Dose-dependence of neuroprotective effects of selected herbal extracts and purified compounds. The herbal extracts,
Glycyrrhiza glabra (A, left panel), Schizandra chinensis is (B, left panel) and Polygonum cuspidatum (C, left panel), were used in the
concentration range of 3 – 100 μg/ml. The pure compounds, glabridin (A, right panel), schisandrin (B, right panel) and resveratrol (C, right
panel) were used in the range of 1 – 65 μg/ml. * p value < 0.05; ** p value < 0.01, and *** p value < 0.001 compared with the positive control.
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of chemical components have been isolated from this
herb including anthraquinones, stilbenes, flavonoids, lig-
nin and their derivatives [23]. In Kim et al.’s study, one
of the fractions from the P. cuspidatum extract, contain-
ing the highest stilbene and anthraquinones, showed the
strongest neuroprotective effects in both a non-celluarantioxidant assay and in a rat model of transient cerebral
ischemia [22]. Our data showed that a standardized P.
cuspidatum extract containing 50% resveratrol (con-
firmed by HPLC/MS analysis, not illustrated) exhibited
both potent anti-oxidant capacity and neuroprotective
effects. We further found that resveratrol itself was neu-
roprotective suggesting that neuroprotective effects of
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dominantly due to its content of resveratrol.
Resveratrol has stimulated considerable research interest
due to its pharmacological effects including antioxidant,
anti-aging, anti-inflammatory and anti-neoplastic activities,
and immune regulation. Interestingly, in our study, the
herbal extract with molar equivalent amount of resveratrol
showed slightly higher neuroprotective activity than pure
resveratrol, suggesting multiple components apart from
resveratrol in the extract may be involved in and additive
to the positive effects. Although P. multiflorum is a close
relative of P. cuspidatum in the Polygonaceae family, the
former did not exhibit neuroprotective effects in our exper-
iments, but proved to be toxic to neuronal cells. Instead of
resveratrol, which was not detected in the extract (data not























































Figure 4 Correlation analysis between the neuroprotective activity an
activity of the herbal extracts was normalized to the cytotoxicity of stauros
cellular DPPH, ORAC and FCR assays. Gallic acid equivalence (GAE) was use
curves were plotted and the correlation level was analyzed for all 13 herba
(4), G. glabra (5), S. chinensis (12), and P. cuspidatum (13), using GraphPad P2,3,5,4′-tetrahydroxystilbene 2-O-β-D-glucoside (THSG)
as the main bioactive component [24]. Compared to P. cus-
pidatum extract, relatively, P. multiflorum extract had
slightly lower, but still strong antioxidant capacity deter-
mined by the non-cellular assays. Our data suggests that
the glycation of resveratrol (to form stilbene glucoside)
may prevent P. multiflorum from having neuroprotective
effects in staurosporine-induced apoptosis. In contrast to
its lack of neuroprotective activity, P. multiflorum exhibited
potent cytoprotective activity in hydrogen peroxide treated
astroglial cells [15].
S. chinensis also exhibited significant neuroprotective
activity comparable with P. cuspidatum. Since the major
constituents of S. chinensis are lignans, among which,
schisandrin is present at the highest concentration [25],
we tested various concentrations of pure schisandrin butB




























































d antioxidant capacity of the herbal extracts. The neuroprotective
porine (100%). The antioxidant activities were determined by non-
d for relative quantification of the antioxidant activity. The correlation
l extracts (A) and for selected bioactive herbal extracts (B), G. lucidum
rism software.
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work will be required to identify the neuroprotective
components of this extract. The relatively small neuro-
protective effect of G. glabra was compared with glabri-
din, a major flavonoid of G. glabra. Glabridin showed a
significant neuroprotective effect in a dose-dependent
manner, but in a narrow range up to 10 μg/ml, confirm-
ing the previously published neuroprotective effect of
glabridin [26].
Antioxidant activity of herbal extracts and the correlation
with their neuroprotective activities
We determined the antioxidant capacity of the extracts
using three non-cellular assays measuring the total phe-
nol content (FCR assay), 2,2-diphenyl-1-picrylhydrazyl
(DPPH) radical scavenging capacity and oxygen radical
absorbance capacity (ORAC). The ranking of their anti-
oxidant activity and phenolic content showed a similar
pattern in the three assays [15]. The three herbal ex-
tracts with the highest antioxidant activity were Rhodiola
rosea > P. cuspidatum > P. multiflorum (DPPH) and P.
cuspidatum > P. multiflorum > R. rosea (ORAC); and
with the highest phenolic content were in P. cuspidatum
> R. rosea > P. multiflorum (FCR).
Comparison of the data from the antioxidant capacity
assays with those from the staurosporine assay suggested
that they appeared to be correlated. Correlation analysis
confirmed the strong correlation with the correlation
co-efficient (r) equal to 0.93 (DPPH), 0.80 (ORAC) and
0.81 (FCR) respectively (Figure 4). The data suggest that
the neuroprotective activity of these herbal extracts was
correlated with their antioxidant capacity and phenolic
content determined in non-cellular assays. Interestingly,
however, the P. multiflorum and R. rosea extracts proved
to be the exception as they exhibited a high level of anti-
oxidant capacity in all three assays, but did not exhibit
neuroprotective effects in the cell-based assay. These re-
sults suggest that high antioxidant activity alone is not a
predictor of cytoprotective activity and the mechanistic
contribution of antioxidant effects of plant secondary
metabolites needs to be established on a case-by-case
basis. It is possible that antioxidant effects of plant-
derived compounds are merely epiphenomena; easily
assayed but not necessarily biologically relevant.
Conclusion
The results from this study demonstrate that G. lucidum,
G. glabra, S. chinensis and P. cuspidatum significantly pro-
tected primary cortical neurons from staurosporine in-
duced cell death. The neuroprotective effects of the P.
cuspidatum extract appeared to be predominantly due to
its major ingredient, resveratrol, but were more effective
based on equivalence of resveratrol concentrations. The
neuroprotective activity of these herbal extracts wascorrelated with their antioxidant capacity. Interestingly,
some extracts exhibited selective protection in neurons
but not glia (P. cuspidatum) or glia but less so in neurons
(P. multiflorum). Together, the data appear to support the
traditional practice of combining multiple herbal medi-
cines for the treatment of complex disorders [15].
Our findings provide experimental evidence that jus-
tify future in vivo studies to lay the ground for or finally
refute the scientific and rational use of this category of
herbal medicines to promote healthy aging. At present,
however, caution is warranted as some herbal medicines
may in fact exhibit neurotoxic effects.
Additional file
Additional file 1: Table S1. Traditional Chinese herbal medicines used
in this study, their extraction and major phytochemical constituents.
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